Market Research Report
Asia Pacific Proteomics Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||823176|
|Published||Content info||110 Pages
Delivery time: 2-3 business days
|Asia Pacific Proteomics Market Forecast 2019-2027|
|Published: April 15, 2019||Content info: 110 Pages||
Proteomics can explain questions that were unsolved by genomics, as proteins are the functional unit of cells. The Asia Pacific proteomics is estimated to grow from $XX billion in 2018 to $XX billion by 2027, at a CAGR of 16.54% between 2019 and 2027. Japan dominated the overall market in terms of revenue in 2018 and Japan is expected to be the fastest growing market over the forecast period in the APAC proteomics market.
The Asia-Pacific provides several lucrative opportunities for the expansion of the proteomics market, owing to the rise in demand for drug discovery and advances in the biotechnology sector. The proteomics market witnessed rapid development in recent years.
The economies of China, India, Japan, South Korea, Australia and the Rest of Asia Pacific are the major contributors by revenue to the regional market for proteomics in APAC. Japan is had dominated the global scenario in 2018 significantly because of the growing life sciences research infrastructure in the country that is fast-tracking its market growth.
Waters Corporation, Bio-Rad Laboratories, Inc., LI-COR Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Horiba, Ltd., Qiagen N.V., General Electric Company, Bruker Corporation, Merck & Company Inc., Caprion Biosciences (acquired by GHO Capital), GlaxoSmithKline, Luminex Corp., Agilent Technologies, Inc., and PerkinElmer, Inc. are the eminent market players which are mentioned in the report.